4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-002817
VP Clinical Reg Affairs bought 500 shares at $18.47 ($9,235)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2022-01-31 | Purchase | +500 | $18.47 | $9,235 | 255,495 | D |
| Open-market purchases · 500 sh · avg $18.47 · $9,235 | |||||||
Loading xslF345X03/ownership.xml…